Telehealth policy changes, rapid mobile technology developments, and consumer demand for virtual behavioral health services are driving a proliferation of digital behavioral health services, including virtual service delivery platforms and mHealth applications, which includes FDA-approved digital therapeutics. These digital services are reshaping the behavioral health treatment landscape in the U.S. Venture capital-backed digital platforms like Spring Health ($2bn) now deliver therapy as well as medication prescribing. This webinar will bring together academic, business, and industry leaders to discuss the evolution of this industry, its efficacy, and what is in store for the future.
Steve Blumenfield is head of Innovation & Acceleration at Willis Towers Watson. He previously has hosted the Cure for the Common Co. podcast. He is a healthcare, insurtech and talent-focused strategist, product and marketing leader, author, and speaker. He has a history of successful product, business and partnership launches, and management in leadership roles.
Adam Chekroud, PhD, is cofounder of Spring Health, a comprehensive mental health benefit for employers. It helps employees understand their mental health issues and connect with best-in-class providers to get the right treatment at the right time. As an academic, Adam develops computational approaches to improve the treatment of mental illness, largely through better matching of specific symptom profiles with specific medications, treatments, or exercise regimens.
Lisa Marsch, PhD, is Director of the Dartmouth Center for Technology and Behavioral Health, a designated “Center of Excellence” supported by the National Institute on Drug Abuse at the National Institutes of Health. She is also the Director of the Northeast Node of the National Drug Abuse Clinical Trials Network based out of Dartmouth and the Andrew G. Wallace Professor within the Department of Psychiatry at the Geisel School of Medicine at Dartmouth College.And she leads a national “Science of Behavior Change” initiative supported by the National Institutes of Health with partners at Dartmouth, Stanford, Arizona State University, Drexel, and MIT.
Matthew Eisenberg, PhD, is an Associate Professor at Johns Hopkins Bloomberg School of Public Health. He is also a member of the HBHI Leadership Team.
Beth McGinty, PhD, MS, is Chief of the Division of Health Policy and Economics and Livingston Farrand Professor of Public Health at Weill Cornell Medicine. She is also an HBHI Affiliate Scholar.
Conversations on the Business of Health Webinar Series
This event is part of a larger series on 'Conversations on the Business of Health,' which will be one-hour webinars that will engage leaders in business and academia. We will explore questions such as:Should companies invest in their employees’ health? Are companies responsible for the health consequences of their products? Will artificial intelligence actually advance health? How can business offer healthcare in novel settings?
Moderated by faculty members and jointly hosted by the Bloomberg School of Public Health, the Carey Business School, the School of Nursing, and the School of Medicine, the series is open to all. Indeed, we invite you to spread the word as we seek participants both inside and outside of Johns Hopkins, including the business world.
Seminars will be on a Friday from noon to 1 p.m. unless otherwise noted.